tiprankstipranks
ADC Therapeutics Ltd (ADCT)
:ADCT
US Market

ADC Therapeutics (ADCT) Financial Statements

Compare
341 Followers

ADC Therapeutics Financial Overview

ADC Therapeutics's market cap is currently $139.71M. The company's EPS TTM is $-1.657; its P/E ratio is ―; ADC Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 69.28M$ 69.56M$ 209.91M$ 33.92M$ 0.00
Gross Profit$ 63.33M$ 67.03M$ 205.33M$ 32.52M$ -1.97M
Operating Income$ -130.65M$ -165.99M$ -123.63M$ -261.72M$ -219.26M
EBITDA$ -130.65M$ -146.76M$ -108.06M$ -223.72M$ -219.26M
Net Income$ -157.85M$ -240.05M$ -155.80M$ -230.03M$ -246.29M
Balance Sheet
Cash & Short-Term Investments$ 250.87M$ 278.60M$ 326.44M$ 466.54M$ 439.19M
Total Assets$ 321.98M$ 354.78M$ 529.17M$ 617.97M$ 513.69M
Total Debt$ 328.09M$ 124.38M$ 117.38M$ 101.75M$ 41.87M
Net Debt$ 77.22M$ -154.22M$ -209.07M$ -364.79M$ -397.32M
Total Liabilities$ 524.62M$ 503.03M$ 440.44M$ 451.88M$ 178.19M
Stockholders' Equity$ -202.64M$ -148.25M$ 88.73M$ 166.09M$ 335.50M
Cash Flow
Free Cash Flow$ -124.70M$ -121.90M$ -139.09M$ -239.75M$ -171.54M
Operating Cash Flow$ -123.83M$ -118.69M$ -136.79M$ -233.38M$ -168.73M
Investing Cash Flow$ -867.00K$ -3.22M$ -2.51M$ -6.67M$ -2.83M
Financing Cash Flow$ 97.05M$ 73.88M$ -593.00K$ 267.39M$ 494.97M
Currency in USD

ADC Therapeutics Earnings and Revenue History

ADC Therapeutics Debt to Assets

ADC Therapeutics Cash Flow

ADC Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis